Free Trial

Nuformix (NFX) Competitors

Nuformix logo
GBX 0.05 0.00 (-8.00%)
(As of 12/20/2024 12:01 PM ET)

NFX vs. OCTP, OVB, PEBI, VAL, ABZA, VER, HEMO, BTG, ABC, and ONT

Should you be buying Nuformix stock or one of its competitors? The main competitors of Nuformix include Oxford Cannabinoid Technologies (OCTP), Ovoca Bio (OVB), Port Erin Biopharma Investments (PEBI), ValiRx (VAL), Abzena (ABZA), Vernalis (VER), Hemogenyx Pharmaceuticals (HEMO), BTG (BTG), Abcam (ABC), and Oxford Nanopore Technologies (ONT). These companies are all part of the "biotechnology" industry.

Nuformix vs.

Nuformix (LON:NFX) and Oxford Cannabinoid Technologies (LON:OCTP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends.

In the previous week, Nuformix's average media sentiment score of 0.00 equaled Oxford Cannabinoid Technologies'average media sentiment score.

Company Overall Sentiment
Nuformix Neutral
Oxford Cannabinoid Technologies Neutral

0.1% of Nuformix shares are held by institutional investors. Comparatively, 14.1% of Oxford Cannabinoid Technologies shares are held by institutional investors. 12.4% of Nuformix shares are held by insiders. Comparatively, 29.8% of Oxford Cannabinoid Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Nuformix has higher revenue and earnings than Oxford Cannabinoid Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuformix£50K7.54-£1.20MN/AN/A
Oxford Cannabinoid TechnologiesN/AN/A-£4.24MN/AN/A

Nuformix has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Oxford Cannabinoid Technologies has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

Nuformix received 68 more outperform votes than Oxford Cannabinoid Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
NuformixOutperform Votes
68
66.67%
Underperform Votes
34
33.33%
Oxford Cannabinoid TechnologiesN/AN/A

Nuformix's return on equity of -27.25% beat Oxford Cannabinoid Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
NuformixN/A -27.25% -17.20%
Oxford Cannabinoid Technologies N/A -86.76%-53.92%

Summary

Nuformix beats Oxford Cannabinoid Technologies on 7 of the 9 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NFX vs. The Competition

MetricNuformixBiotechnology IndustryMedical SectorLON Exchange
Market Cap£377,000.00£165.68M£5.14B£1.90B
Dividend YieldN/A3.64%5.09%5.55%
P/E Ratio-1.63115.5190.051,821.81
Price / Sales7.5418,531.021,117.09386,342.76
Price / Cash3.5512.8743.1028.54
Price / BookN/A8.594.782.78
Net Income-£1.20M-£20.67M£120.31M£157.16M
7 Day PerformanceN/A-1.05%-1.92%-2.00%
1 Month PerformanceN/A174.77%13.65%21.23%
1 Year PerformanceN/A134.18%28.34%29.20%

Nuformix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NFX
Nuformix
N/AGBX 0.05
-8.0%
N/A-83.6%£377,000.00£50,000.00-1.633Gap Up
OCTP
Oxford Cannabinoid Technologies
N/AGBX 0.12
-4.2%
N/AN/A£1.25MN/A-53.107Gap Down
OVB
Ovoca Bio
N/AGBX 1.50
-3.2%
N/A+78.7%£1.22MN/A-38.755Gap Down
PEBI
Port Erin Biopharma Investments
N/AGBX 4.50
+∞
N/AN/A£1.04M£28,300.00-6.43N/AGap Up
VAL
ValiRx
N/AGBX 0.72
-1.4%
N/A-88.3%£946,000.00N/A-36.255,450
ABZA
Abzena
N/AGBX 15.75
flat
N/AN/A£0.00N/A0.00N/A
VER
Vernalis
N/AGBX 6.17
flat
N/AN/A£0.00N/A0.00350
HEMO
Hemogenyx Pharmaceuticals
N/AGBX 343.77
-9.1%
N/A+16,252.4%£4.61BN/A-28,400.0014High Trading Volume
BTG
BTG
N/AGBX 840
+0.1%
N/AN/A£3.26B£914.10M29.474,690News Coverage
ABC
Abcam
N/AGBX 1,226
+11.2%
N/AN/A£2.81B£350.40M20,433.331,650Gap Up
High Trading Volume
ONT
Oxford Nanopore Technologies
1.55 of 5 stars
GBX 156.60
-0.3%
GBX 235.50
+50.4%
-30.7%£1.47B£167.75M-785.001,281Positive News

Related Companies and Tools


This page (LON:NFX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners